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Abstract 
Background: Bone-anchored hearing aids (BAHAs) are indicated for people with conductive or mixed 
hearing loss who can benefit from amplification of sound. In resource limited health care systems it is 
important that evidence regarding benefit of BAHAs is critically appraised to aid decision making. 
Objective of review: To assess the clinical effectiveness of BAHAs for people with bilateral hearing 
impairment. 
Type of review: Systematic review. 
Search strategy: Nineteen electronic resources were searched from inception to November 2009. Additional 
studies were sought from reference lists, clinical experts and BAHA manufacturers. 
Evaluation method: Inclusion criteria were applied by two reviewers independently. Data extraction and 
quality assessment of full papers were undertaken by one reviewer and checked by a second. Studies were 
synthesised through narrative review with tabulation of results. 
Results: Twelve studies were included. Studies suggested audiological benefits of BAHAs when compared 
with bone conduction hearing aids or no aiding.  A mixed pattern of results was seen when BAHAs were 
compared to air conduction hearing aids. Improvements in quality of life with BAHAs were found by a 
hearing-specific instrument but not generic quality of life measures. Issues such as improvement of 
discharging ears and length of time the aid can be worn were not adequately addressed by the studies. 
Studies demonstrated some benefits of bilateral BAHAs. Adverse events data were limited. The quality of 
studies was low. 
Conclusions: The available evidence is weak. As such, caution is indicated in the interpretation of presently 
available data. However, based on the available evidence BAHAs appear to be a reasonable treatment option 
for people with bilateral conductive or mixed hearing loss. Further research into the benefits of BAHAs, 
including quality of life, is required to reduce uncertainty. 
 
 
Keypoints 
• Twelve studies were included; these were either one group before-and-after studies or cross sectional 
‘audiological comparison’ studies. 
• The weak methodological quality of the studies means their results should be viewed with caution. 
• The included studies focused on hearing capacity. There is an absence of good quality evidence on the 
effects of BAHAs on quality of life, adverse events and issues such as improvement of discharging ears.   
• Research designed to have a low risk of bias is required to underpin clinical decision making. Studies 
should focus on cost benefits, efficacy regarding audiometric measures, efficacy regarding disease 
control (e.g. reduced need for Otolaryngology input), and efficacy regarding patient perceived benefits of 
BAHA.  
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Background 
Bone-anchored hearing aids (BAHAs) are indicated for people with conductive or mixed hearing loss who 
can benefit from amplification of sound, but are unable to use conventional air-conduction hearing aids.  
BAHAs are more expensive than air-conduction hearing aids, as they require surgery to fit the abutment and 
the amplification devices are more costly.  Until recently, the hearing aid sound processing technology used 
was essentially a single channel analog design.  Newer devices utilise multiple channels of sound processing, 
directional microphones, non-linear compression, feedback cancellation and noise reduction strategies, and 
these features are manipulated using  fitting software.1 However, the candidacy criteria for BAHAs have not 
altered as a result of the introduction of new sound processing technology. 
 
Formal records of the number of BAHAs in use do not exist. It is thought that there are about 6000 to 7000 
BAHAs in current use in the UK (David Proops, Birmingham Children’s Hospital NHS Trust, March 2010) 
and suggestions that as many as 50,000 people have been fitted with a BAHA worldwide,2 which includes  
people with single-sided as well as bilateral hearing loss. The number of people who could potentially 
benefit from a BAHA is uncertain as prevalence data focusing on conductive or mixed hearing loss are not 
readily available. Access to BAHA provision is variable throughout the developed world and funding is not 
universally available. Moreover, the clinical effectiveness of the BAHA is unclear. 
 
People with bilateral hearing loss are most commonly fitted with a unilateral BAHA. However, it has been 
suggested that those with bilateral BAHAs benefit in terms of greater stimulation levels at the cochlea, better 
directional hearing and space perception, and better speech recognition in noise.3-7 In a consensus statement 
from international (Europe and US) BAHA experts in 2005, bilateral application with thorough counselling 
was advocated in young children with severe congenital conductive hearing impairment.8 The clinical 
efficacy of bilateral BAHAs, however, is still debatable. 
 
Objective of review 
Given the uncertainty surrounding the use of BAHAs, a synthesis of the available evidence on the benefits 
and harms of unilateral and bilateral BAHAs in bilateral hearing loss was undertaken to provide more 
direction to both providers of health care and people with hearing loss. We aimed to synthesise the highest 
quality evidence available to determine: 
1) What is the clinical effectiveness of BAHAs compared with conventional air- and bone-conduction 
hearing aids, ear surgery and unaided hearing in bilateral hearing loss?  
2) What is the clinical effectiveness of bilateral BAHAs compared with unilateral BAHAs in bilateral 
hearing loss? 
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This paper summarises the results of the systematic review of clinical effectiveness conducted as part of a 
project commissioned by the UK National Institute for Health Research Health Technology Assessment 
programme.9  
 
Methods 
Search strategy 
Nineteen electronic databases, including MEDLINE, EMBASE and The Cochrane Library, were searched 
from their inception to November 2009 for published and ongoing studies, with no language restrictions (full 
details of the search strategy are available elsewhere 9). Additional references were identified from 
bibliographies of retrieved articles, experts and BAHA manufacturers. 
 
Evaluation method 
Two reviewers independently screened studies for inclusion according to predefined criteria: 
• Population: children or adults with bilateral hearing impairment; 
• Intervention: BAHA (fitted unilaterally or bilaterally); 
• Comparisons: BAHA versus bone-conduction hearing aids, air-conduction hearing aids, unaided 
hearing or ear surgery; unilateral BAHAs versus bilateral BAHAs; 
• Outcomes: audiometric thresholds, aided audiometric thresholds (pure-tone and warble tone), speech 
recognition scores, validated measures of quality of life and patient satisfaction, adverse events; 
• Study design: Prospective controlled studies, prospective one group before-and-after studies, cross-
sectional ‘audiological comparison’ studies, prospective case series (no comparator condition). Only 
studies with the most rigorous designs were included for each comparison. Where higher level 
evidence was limited to BAHA models no longer in current use, lower level evidence for models in 
current use was considered. 
 
Data extraction and quality assessment were undertaken by one reviewer and checked by a second reviewer. 
Where necessary, data were estimated from figures and/or means and standard deviations were calculated. 
Methodological quality and quality of reporting were assessed using standard criteria,10 which were modified 
to accommodate the types of studies included in this review. During study selection, data extraction and 
quality assessment, any differences in opinion were resolved by consensus or a third reviewer. 
 
A meta-analysis was inappropriate due to differences in outcome measures and patient populations. Studies 
were synthesised through a narrative review with full tabulation of results.9 In reporting the results of studies 
the original terminology used in the papers has been used. Where this is obscure or unclear, a note of 
explanation has been inserted if possible. 
 
Results 
Quantity and quality of research 
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A flowchart showing the number of references excluded at each stage of screening is shown in Figure 1.  
Twelve studies (reported in 15 publications) were included in the systematic review. The included studies 
were either one group cohort before-and-after studies or cross sectional ‘audiological comparison’ studies. 
Only two studies included BAHA models that are in current use.11,12 No eligible studies comparing BAHAs 
with ear surgery were identified. 
Twenty-eight potentially relevant non-English language papers were identified (list available elsewhere9). 
Examination of the titles and English abstracts (where available) suggested none had a concurrent control 
group and it was unclear whether any of the studies met the inclusion criteria. Due to the limited value it was 
anticipated these studies would add to the review and in view of limited resources, these studies were not 
assessed further. 
Characteristics of included studies are presented in Table 1. All 12 included studies were rated overall as 
‘weak’ for their methodological quality and quality of reporting, providing the opportunity for bias (see 
Table S1 for a summary of methodological quality). The types of biases apparent in some of the studies 
include selection bias (participants may not be representative of the target population); performance bias 
(bias in the care provided); measurement or detection bias (how outcomes are assessed); and attrition bias 
(bias in withdrawals and dropouts). Any observed treatment effects could be due to bias, or a treatment effect 
could be obscured by bias. These biases could lead to overestimation or underestimation of the true effect.  
 
BAHAs versus bone-conduction hearing aids 
Four cohort before-and-after studies13-18 included a comparison of BAHAs and bone-conduction hearing aids 
(Table 2). Improvements in the average sound field pure-tone or warble tone thresholds were found with a 
BAHA by two studies,13,14 but statistical analysis was reported by only one of these (p<0.01).14 A third study 
did not report thresholds averaged across frequencies, but found improved thresholds with the bone-
conduction hearing aid at 0.25 kHz and 0.5 kHz, and with the BAHA at higher frequencies.16 No statistical 
analysis was undertaken.  
 
Speech discrimination tests varied between the studies (Table 2). A statistically significant improvement in 
speech reception threshold in quiet was found in people with a sensorineural loss of less than 30 dB HL.18 
Another study found no statistically significant difference in sound field speech discrimination scores.14 
Statistical analyses were not reported for other results from the included studies (Table 2).  
 
Two studies reported using a validated measure of quality of life,13,15 although limited data were presented by 
one of the studies13 (see Table S2 for a summary of quality of life scores). The second study found no 
statistically significant differences between bone-conduction hearing aids and BAHAs using the 36-Item 
Short-Form Health Survey (SF-36) and European Quality of Life-5 Dimensions (EQ-5D), however a 
statistically significant improvement with a large clinical impact was found for handicap and disability with 
the Hearing Handicap and Disability Index.15 
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The number of otolaryngology visits over the preceding six months for draining ears was reported by one 
study, which found these to reduce from a mean of 5.4 (SD 4.19, range 0 to 20) visits with a bone-
conduction hearing aid to a mean of 1.5 (SD 2.1, range 0 to 6) visits with a BAHA (statistical significance 
not reported).15  
 
Four studies reported the results of subjective questionnaires on patient preference,13,15,18 satisfaction,14 
comfort16 and self-report of speech recognition in noise and quiet.14,16-18 None of these questionnaires 
appeared to have been validated. The data from these studies can be viewed elsewhere,9  however care 
should be taken when interpreting results due to the issues associated with non-validated questionnaires. 
 
BAHAs versus air-conduction hearing aids 
Five cohort before-and-after studies14-20 and one cross-sectional study11 included a comparison of BAHAs 
and air-conduction hearing aids (Table 3). The direction of effect for sound-field pure tone or warble tone 
thresholds was inconsistent between the five studies reporting hearing threshold data. Two studies reported a 
statistically significant improvement in mean sound field warble tone thresholds,11,14 whilst another study 
described their data on average warble tone thresholds (0.2 to 4 kHz) as ‘comparable’ between BAHAs and 
air-conduction hearing aids, but did not provide statistical analysis.19 Three studies presented thresholds at 
each frequency individually, but there was no clear pattern as to the comparative benefits of air-conduction 
hearing aids and BAHAs.11,16,20 
 
The direction of the effect was also unclear for speech audiometry, with some studies finding better 
outcomes with the air-conduction hearing aid and some with the BAHA. A variety of different test protocols 
were used by the studies.  Two studies reported better outcomes with the air-conduction hearing aid for mean 
sound field speech discrimination scores,19 or for maximum phoneme score and speech recognition 
threshold.16 However, statistical analysis was not conducted (Table 3). A later publication with a different 
patient group (less severe hearing loss), found a statistically significant decrement in mean speech reception 
threshold in quiet with the BAHA (p<0.05), but a statistically significant improvement in discrimination of 
speech in background noise (as measured by speech to noise ratio, p<0.05).18 One study found no statistically 
significant difference in the maximum phoneme score, but a statistically significant improvement in speech 
in noise ratio with the BAHA.20 Speech discrimination scores were statistically significantly better with the 
BAHA in the congenital aetiology group, but not the chronic suppurative otitis media group in one study.14 
The final study reported an improvement with the BAHA in speech understanding in noise described as 
‘large and clinically significant’ in participants with mixed hearing loss.11  
 
One study reported using a validated measure of quality of life, which was assessed using an air-conduction 
hearing aid prior to BAHA surgery and again after six months experience with a BAHA15 (see Table S3 for a 
summary of quality of life scores). A statistically significant increase in anxiety/depression with BAHAs was 
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found by the EQ-5D, but the clinical effect was small. No other statistically significant differences were 
found between air-conduction hearing aids and BAHAs by the EQ-5D or the SF-36, however a statistically 
significant improvement with a large clinical impact was found for handicap and disability with the Hearing 
Handicap and Disability Index.15 
 
The number of otolaryngology visits over the preceding six months for draining ears was reported by one 
study, which found a reduction with BAHAs compared with air-conduction hearing aids [mean visits 12.7 
(SD 10.5) versus 3.3 (SD 4.8)], however statistical analysis was not undertaken.15  
 
Five studies reported the results of subjective questionnaires on patient preference,15,18-20 satisfaction,14 
comfort 16,19 and opinions on speech recognition in noise and quiet.14,16-18 None of these questionnaires 
appeared to have been validated. The data from these studies can be viewed elsewhere,9 but as previously 
stated, care should be taken when interpreting the results. 
 
BAHAs versus unaided hearing 
Four cohort before-and-after studies12-14,19 included a comparison of BAHAs with unaided hearing (Table 4). 
All four studies found improvements in sound field thresholds (pure-tone or warble tone) with the BAHA 
compared with unaided hearing thresholds, and these improvements were statistically significant in the two 
studies that conducted analysis.12,14  
 
Improvements were found in sound field speech discrimination scores,14,19 speech recognition scores,12 
speech recognition threshold in quiet12 and speech recognition in noise.12 However, statistical analysis was 
not undertaken (Table 4). No self-report measures were reported by these four studies.  
 
Unilateral versus bilateral BAHAs 
Four cross sectional studies3,5,21-23 compared performance on audiological measures with unilateral versus 
bilateral BAHAs (Table 5). The participants in the included studies all underwent sequential (separate 
operations) implantation of the bilateral BAHAs.  
 
Two studies reported data on hearing thresholds. Sound-field average tone thresholds were improved with 
bilateral BAHAs compared with unilateral BAHAs in adults23 and a small group (n=3) of children3 with 
previous experience of bilateral BAHAs, but statistical analysis was not undertaken (Table 5).  
 
Two studies found speech recognition thresholds in quiet were statistically significantly better with bilateral 
BAHAs5,23 (Table 5). Another study found all 11 participants scored 100% with right, left and bilateral 
BAHAs for sound field speech in quiet.22  
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Different tests of speech in noise demonstrated that bilateral BAHAs produced better results than one BAHA 
when noise was presented from baffle/better hearing side (the side with the BAHA in the unilateral 
condition), but not when noise was presented from the shadow side (the side opposite to the BAHA in the 
unilateral condition).5,22,23  
 
Three studies demonstrated that sound localisation abilities were improved with bilateral BAHAs.3,5,23 
Correct localisation, localisation within 30˚ and lateralisation measured at 0.5 kHz and 2 kHz were 
significantly better than chance with bilateral BAHAs, but not with unilateral BAHAs, in the study by 
Bosman and colleagues. Bilateral BAHAs performed statistically significantly better than unilateral 
BAHAs.5,21 (Table  5).   
 
Priwin and colleagues found similar results in their studies of twelve adults23 and nine children,3 although no 
statistical analyses were undertaken. In the first study, accuracy of sound localisation with a unilateral 
BAHA on the best or shadow side were close to the chance level, while with a bilateral BAHA the accuracy 
improved. Similarly, the second study found an improvement in sound localisation and sound lateralisation 
abilities with bilateral BAHAs, while with unilateral BAHAs the results were close to chance levels3 (Table 
5). Two studies used the binaural masking level difference test to suggest that BAHAs give binaural 
hearing.5,23 However, it has been argued that the interpretation of some listening tests with bilateral BAHAs 
is complex, due to effects arising from cross hearing, and is currently incomplete (see Rowan & Gray 200824 
for background on these issues).  
 
One study3 described self-report measures using validated tools to assess hearing skills in ‘meaningful, real 
world situations’ and hearing aid outcomes (see Table S4). Scores appeared similar between unilateral and 
bilateral BAHA users for most items, however given the very small sample sizes (n=2 to n=6), these results 
should be interpreted with caution.  
 
Adverse events 
Only three of the included studies reported minimal data on adverse events13,18,20 (Table 6), therefore 
additional data from prospective case series were sought. It should be noted that these studies did not 
undergo the same process of data extraction and quality assessment. Five prospective case series were 
identified25-29 (see Table S5 for a summary of these studies) and reported loss of implants between 6.1% (9 to 
25 months follow-up)28 and 19.4% (median 6 years follow-up).25  The vast majority of participants in the 
prospective case series experienced no or minor skin reactions. 
 
Discussion 
Clinical applicability of the study 
Whilst the evidence base is not strong, it appears that when applied to bilateral conductive or mixed hearing 
loss, audiometric outcomes from BAHA are good and adverse events are rarely reported. Based on the 
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available evidence BAHAs are a reasonable treatment option for consideration by health care 
commissioners, clinicians and patients, however further research would reduce the uncertainties regarding 
BAHAs. 
 
Synopsis of key findings 
The findings of this review suggest that hearing is improved with BAHAs compared with unaided hearing, 
and while there appear to be some audiological benefits of BAHAs when compared with conventional bone-
conduction hearing aids, the limited evidence base does not provide a reliable estimate of the degree of 
benefit.  The audiological benefits of BAHAs when compared with air-conduction hearing aids are less clear.  
Limited data suggest an improvement in quality of life with BAHAs when compared with conventional aids, 
but this was identified by the hearing-specific instrument and not generic quality of life measures. There is 
an absence of reliable evidence regarding other potential benefits, such as length of time the aid is able to be 
worn and improvement of discharging ears.  The evidence suggests there are some benefits of bilateral 
BAHAs compared with unilateral BAHAs in many, but not all, situations, and the presence of binaural 
hearing with bilateral BAHAs remains uncertain. 
 
Comparisons with other studies 
These findings are broadly in line with those of a previous systematic review,30 which assessed the 
nonacoustic (self-report generic and disease-specific quality of life) benefits of BAHAs. The authors of the 
previous review concluded that there is limited statistically supported, empirically controlled evidence 
supporting the nonacoustic benefits of BAHAs relative to more conventional hearing aids or no hearing aids 
at all. However, the previous review was limited to nonacoustic outcomes and no other systematic reviews of 
BAHAs for bilateral hearing loss were identified. 
 
Strengths and limitations of the systematic review 
This systematic review brings together the evidence for the clinical effectiveness of BAHAs for people with 
bilateral hearing impairment. This evidence has been critically appraised and presented in a consistent and 
transparent manor following the principles for conducting as systematic review. The methods were set out in 
a research protocol which defined the research question, inclusion criteria, data extraction and quality 
assessment process and methods to be employed at different stages of the review. The conclusions drawn 
from the present systematic review are constrained by the limitations of the available evidence. Despite a 
wide ranging and systematic search, no prospective trial with a concurrent control group was identified. 
There is a high risk of bias in the included studies. Synthesis of the included studies was through narrative 
review as differences in participants, comparator and outcome measures meant that meta-analysis was 
inappropriate. No prospective study comparing BAHAs with ear surgery was identified, therefore no 
conclusions could be drawn.  The non-English language references identified by the searches were not 
translated and screened. However, none of these papers appeared to present higher level evidence and it is 
unlikely that the inclusion of additional lower level evidence would change the conclusions of this review.  
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The studies reviewed date from the inception of BAHAs to November 2009 (date of the literature searches). 
During that time period the hearing aid sound processing technology used was essentially a single channel 
analog design; however devices that utilise new sound processing technology have recently been 
released to market by different manufacturers. Research reports indicating improved audibility with such 
technology are beginning to appear in the conference literature, but whilst these devices are more adaptable, 
and that may bring some incremental improvement in performance in some users, the candidacy criteria for 
BAHAs have not altered. As such the results of the analysis undertaken in this systematic review can be 
brought to bear on current decisions about the commissioning of BAHA services, and the applicability in an 
individual patient. 
 
To assess whether any new studies have been published since the complete literature searches were 
undertaken in November 2009, we updated the Medline search (May 2011). Of 78 references identified by 
the search strategy, two studies were found to meet the inclusion criteria of the systematic review.31,32 It 
should be noted that these studies did not undergo the process of data extraction and quality assessment 
specified a priori in the systematic review protocol. One study31 compared BAHA with unaided hearing, 
although the BAHA devices used by participants (n=17) included those no longer manufactured as well as 
those in current use. The study found an improvement in outcomes with BAHA versus without BAHA. The 
second study32 compared a relatively new digital BAHA device versus a powerful behind-the-ear device with 
feedback cancellation in 16 selected participants with chronic middle ear problems and dry ears. The authors 
concluded that speech recognition seemed to be better with the BAHA than with the behind-the-ear device in 
patients with mixed hearing loss when the air-bone gap exceeded approximately 35 dB. Whilst it is important 
to acknowledge these studies, formal inclusion of their results in the systematic review would not have 
altered our conclusions.  
 
The outcome measures reported by the included studies have limitations, and it is not always clear what is 
clinically significant or meaningful to the individual. Audiological measures such as hearing threshold levels 
or speech reception levels in quiet have often been applied, but may not be sufficiently sensitive to capture 
the benefit delivered to the individual. We acknowledge that this review has somewhat simplified the 
interpretation of outcomes, where we have assumed that lower hearing thresholds are better than higher 
thresholds throughout the review.  The review used the study authors’ descriptions such as ‘improvement’ or 
‘deterioration’ where available, however no interpretations were offered by many of the included studies. 
Data were often presented only in figures and several studies did not report summary statistics such as means 
and measures of variance. 
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Although the air-conduction hearing aid may produce better audiometric results in some situations, it should 
be noted that the most appropriate hearing aid may not necessarily be the one with the best sound processing 
performance. Other factors such as comfort, the ability to wear the aid and reduced susceptibility to 
infections need to be considered, but these issues have not been adequately addressed by the included 
studies. Some included studies reported patient preference, however the tools used were not validated and 
likely to be biased, especially considering evidence that suggests individuals report preferring the second 
hearing aid tested, even if it is in fact an identical aid.33 
 
Some data were available on the impact of BAHAs on quality of life. One study reported improvements with 
the Hearing Handicap and Disability Index but not the SF-36 or EQ-5D. The Hearing Handicap and 
Disability Index is specific to hearing loss, while the SF-36 and EQ-5D are generic measures that do not 
have a hearing dimension, which may explain the difference in outcomes between the different instruments. 
Important issues related to comfort, discharge and pain are also not adequately addressed by the instruments. 
It is therefore difficult to judge the impact of a BAHA on quality of life from these results.  
 
Conclusions 
In conclusion, the available evidence is methodologically weak and the results have a high risk of bias. As 
such, caution is indicated in the interpretation of results. However, based on the available evidence BAHAs 
appear to be a reasonable treatment option for people with bilateral conductive or mixed hearing loss. Further 
research into the benefits of BAHAs, including quality of life, is required. Whilst the BAHA intervention 
does not lend itself to randomised controlled trial study designs, waiting list control studies would be 
feasible. Further, a comprehensive approach to a number of issues would be beneficial, including: cost 
benefits, efficacy regarding audiometric measures, efficacy regarding disease control (e.g. reduced need for 
Otolaryngology input), and efficacy regarding patient perceived benefits. 
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Figure 1 Flowchart of identification of studies 
 
 
 
 
 
 
 
Lower hierarchy 
Excluded n = 26 
Identified on searching                       
(after duplicate removal)                          
n = 665 
Titles and abstracts 
inspected 
    
Full papers retrieved   
n =   75 
Full papers inspected 
Potentially eligible                                  
n = 41 
Included n = 12 (in 15 publications)                                              
→ cohort pre-post design n = 7       
→ audiological comparison study n = 5 
Excluded n = 562 
Relevant non-
English papers 
 n = 28 
Excluded n =34 
Hierarchy of study design examined 
and studies with BAHA models in 
current use identified 
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Table 1 Characteristics of included studies 
Study  Design Intervention (timing of audiology) N Sex Age 
mean years 
(range) 
Participants indication 
Unilateral: BAHA vs bone-conduction hearing aid 
Béjar-Solar 
et al. 13 
Mexico 
CPP 1. Unaided (pre-op) 
1. BCHA (pre-op) 
2. BAHA Classic 300 (at 6 months) 
11 7M 
4F 
10 (5-7) Inoperable bilateral congenital microtia 
atresia. BC PTA better than 45 dB HL 
with 100% speech discrimination 
Unilateral: BAHA vs air-conduction hearing aid 
aBurrell et al. 
19 
UK 
CPP 1. ACHA (pre-op) 
2. Unaided (unclear if pre- or post-op)b 
3. BAHA Superbass or ear level BAHA (NR) 
9 NR NR Otosclerosis. Average BC thresholds (0.5-
4 kHz) < 40 dB HL for ear level BAHA, 
< 60 dB HL for body worn Superbass 
Flynn et al.11 
Sweden 
ACS 1. BAHA Intenso 
2. ACHA Oticon Sumo DM, digital superpower 
hearing aid (same session) 
10 5M 
5F 
59 (32-75) Mixed hearing loss, no further details. 
Sensorineural hearing loss component ≥ 
25 dB HL plus air-bone gap > 30 dB 
cMylanus et 
al.20 The 
Netherlands 
CPP 1. ACHA (pre-op) 
2. BAHA, model NR (4 to 6 weeks) 
34 12M 
22F 
48 (26-72) Bilateral conductive or mixed hearing loss 
with chronic otitis.  
Unilateral: BAHA versus bone-conduction hearing aid and air-conduction hearing aid, in separate subgroups 
aCooper et 
al.14  
UK 
 
CPP Four subgroups: previous aid AC or BC, 
aetiology CON or CSOM  
1. Unaidedb 
2. Previous aid (pre-op) 
3. BAHA HC 200, 300 or 220 (at 6 months) 
AC 33 
BC 35 
 
NR CSOM/AC 58 
CSOM/BC 61 
CON/AC 30 
CON/BC 24 
Chronic suppurative otitis media or 
congenital aetiology. Average BC 
thresholds (0.5-4 kHz) <40 dB HL (ear 
level) or <60 dB HL (bodyworn), speech 
discrimination score ≥ 60%. 
cHol et al.15 
The 
Netherlands 
 
CPP Two subgroups: previous aid AC or BC 
1. Previous aid (pre-op)  
2. BAHA Classic or Cordelle (at 6 months) 
AC 36 
BC 20 
AC 
12M 
24F 
BC 
9M 
11F 
AC 47.9 (24-
73)  
BC 62.0 (42-
82) 
Acquired conductive or mixed hearing 
loss, no further details. 
 
cSnik et al.16 
17,18 
The 
Netherlands 
 
CPP Two subgroups (previous aid AC or BC):16 
1. Previous aid (pre-op) 
2. BAHA HC220 (at least 4 weeks) 
AC 5 
BC 7 
NR AC 60.6 (34-
84)  
BC 62 (46-78) 
Recurrent otorrhoea. Severe mixed 
hearing loss with sensorineural 
components of 45 to 60 dB HL.16 
 Four subgroups: previous aid AC or BC, current 
BAHA HC200 or HC220 17 
1. Previous aid (pre-op) 
AC 14 
BC 44 
NR NR (10-77) Chronic otitis media/externa, aural atresia. 
Both normal to moderate and more severe 
sensorineural hearing loss. 17 
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2. BAHA HC200 or HC220 (≥ 4 weeks) 
 Two subgroups: previous aid AC or BC: 18 
1. Previous aid (pre-op) 
2. BAHA HC 200 (at least 6 weeks) 
AC 8 
BC 33 
NR 43 (10-70) Conductive or mixed binaural hearing 
loss, sensorineural hearing loss of ≤ 30 dB 
HL. No details of aetiology.18 
Unilateral BAHA versus unaided hearing, see also three studies above13,14,19 
Kompis et al. 
12 
Switzerland 
CPP 1. Unaided (at baseline) 
2. BAHA Divino (at 3 months)  
7 3M 
4F 
49 (19-66) Bilateral conductive hearing loss, some 
mild to moderate sensorineural hearing 
loss.  
Unilateral BAHA versus bilateral BAHAs (all assessed at same session) 
Bosman et 
al.5,21 
The 
Netherlands  
ACS BAHA HC 200 or Classic 300 
1. Unilateral, first implant side 
2. Bilateral 
 
25 14M 
11F 
44.3 (12-74) Recurrent otorrhoea, otitis externa, 
congenital atresia. 
Dutt et al.22 
UK 
 
ACS BAHA Compact 
1. Unilateral, best response, or right and left 
2. Bilateral   
 
11 3M d 
9F 
42.3 (22-54) Treacher Collins syndrome, Goldenhar’s 
syndrome, bilateral: mastoid cavities, 
congenital hearing loss, chronic otitis 
media, microtia, acquired otosclerosis. 
Priwin et al.23 
Sweden  
ACS BAHA Compact or Classic 300  
1. Unilateral, best and shadow side 
2. Bilateral  
12 3M 
9F 
51.7 (27-68) Chronic otitis, otosclerosis, congenital ear 
canal atresia. 
 
Priwin et al.3 
Sweden  
ACS BAHA Compact or Classic. Two groups: 
1. Unilateral - unaided and 1 BAHA  
2. Bilateral – unaided, 1 and 2 BAHAs  
Unilateral 
3 
Bilateral 6 
3M 
6F 
11.3  (6-17) Majority had symmetrical maximal or 
near-maximal conductive bilateral hearing 
loss.   
AC = air conduction; ACHA = air-conduction hearing aid; ACS = cross-sectional ‘audiological comparison study’; BC = bone conduction;  BCHA = bone-conduction hearing aid;  
CON= congenital aetiology, CPP = cohort pre and post study (one group before-and-after study); CSOM = chronic suppurative otitis media; F = female; M = male; NR = not 
reported; PTA = pure tone average.  
a There may be overlap of participants between these studies conducted in the UK. 
b Unaided condition was assessed pre and post-operatively and it is not clear which of these data are presented. 
c There may by overlap of participants between these studies conducted in The Netherlands. 
d 1 patient chose not to participate. 
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Table 2 Audiologic measures: BAHA versus bone conduction hearing aid  
Study and outcomes BCHA BAHA model Comparison Comment 
Béjar-Solar et al.13 (n=11) BCHA   Classic 300  Difference  
Sound field pure-tone average (0.125-3 kHz), dB HL 30 19 -11 (37% 
improvement) 
Standard deviations not reported 
Mean intensity (dB HL) at which 100% speech 
discrimination achieved in background noise at 65 dB 
62 48 -14 (23 % 
improvement) 
Non standard speech test material used: 
“colloquial language common to Mexico City” 
Accurate directional identification of location of a 
sound source (% of cases) 
0 80  “Ability to pinpoint the position of natural 
vocal speech in an area with high background 
nose at a distance of 3m” 
Cooper et al.14  CSOM (n=19), CON (n=16) BCHA HC 200, 300, 220 P value  
Mean sound field warble tone thresholds, dBA (0.5-4 
kHz) 
CSOM 42 
CON 31 
CSOM 35 
CON 26 
p<0.01 
p<0.01  
Student’s t-test 
Mean sound field speech discrimination score (at 63 
dB), % correct  
CSOM 65 
CON 86 
CSOM 72 
CON 85 
p=ns  
p=ns  
Boothroyd word list material used 
Student’s t-test 
Snik et al.16-18 BCHA HC 200, 220 P value  
Snik et al. 1992 16 (n=7) BCHA HC220  “Standard Dutch phonetically balanced word 
lists consisting of 10 monosyllables” 
Maximum phoneme score, %, mean (SD), range 36.1 (28.9), 0 to 
85 
48.7 (31.7), 0 to 
100 
NR  
Speech recognition threshold, dB(A), mean (SD), 
rangeb 
(n=2) 
40 (7.1), 35 to 45 
(n=4) 
38.8 (11.1), 25 to 
50 
NR  
Average difference between the sound field warble 
thresholds (BCHA minus BAHA), dB 
 0.25 kHz 
 0.5 kHz 
 1 kHz 
 2 kHz 
 4 kHz 
 8 kHz 
 
 
2 
3 
-2  
-10 
-14 
NR 
 
Snik et al. 1994 17 (n=44) HC 220, HC 200 “Phonetically balanced monosyllable” material 
used 
Patients with a statistically significant change in: 
- speech recognition in quiet score with BAHA 
HC 220 (n=11) 
Improved: 6 of 11 (54%); Deteriorated: 0 of 11 
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- speech to noise ratio score with BAHA Improved: 5 of 11 (44%); Deteriorated: 0 of 11  
 HC 200 (n=33)  
- speech recognition in quiet score with BAHA Improved:  4 of 33 (12%); Deteriorated: 0 of 33   
- speech to noise ratio score with BAHA Improved: 20 of 33 (60 %); Deteriorated: 0 of 33   
Snik et al. 1998 18 (n=33) HC 200 “Sentence Recognition in Noise” test used 
Change in speech reception threshold in quiet (BCHA 
minus BAHA), mean dB (SD) 
2.7 (4.4),  improvement p<0.05  
Change in speech to noise ratio, mean dB (SD) 2.5 (2.2), improvement  p<0.05  
Note: study authors’ original terminology retained. BCHA = bone-conduction hearing aid; CON = aetiology congenital; CSOM = aetiology chronic suppurative otitis media; NR = not reported; 
SD = standard deviation. 
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Table 3 Audiologic measures: BAHA versus air-conduction hearing aid  
Study and outcomes ACHA BAHA model Comparison Comments 
Burrell et al.19 (n=9) ACHA model NR   
Average sound field warble tone thresholds (0.5 to 4 
kHz), mean (SD), range, dBA 
33 (5.4), 28 to 40  30.6 (8.1), 22 to 
43 
NR  
Sound field speech discrimination at 63 dBA, % 
correct, mean (SD), range 
91.6 (14.7), 60 to 
100  
84 (22.3), 30 to 
100  
NR Boothroyd wordlist material used 
Cooper et al.14   
CSOM (n=24), CON (n=6) 
ACHA HC 200, 300, 220 P value  
Mean sound field warble tone thresholds, (dBA, 0.5-4 
kHz) 
CSOM 40 
CON 41 
CSOM 33 
CON 28 
p<0.01 
p<0.01 
Student’s t-test 
Mean sound field speech discrimination score (at 63 
dB), % correct  
CSOM 69 
CON 57 
CSOM 72 
CON 82 
p=ns 
p<0.05 
Boothroyd word list material used 
Student’s t-test 
Flynn et al.11 (n=10) ACHA Intenso  Difference  
Average aided warble tone thresholds (dB SPL) 
 0.25 kHz 
 0.5 kHz 
 1 kHz 
 2 kHz 
 3 kHz 
 4 kHz 
 6 kHz 
 8 kHz 
 
39 
42 
37 
43 
46 
50 
75 
68 
 
47 
39 
30 a 
31 a 
39 a 
41 a 
53 
55 
p<0.01 overall Statistical test not reported 
Speech-in-noise ratio, dB 3.44  0.88  2.56 “Swedish version of Hearing in Noise test” 
used 
Mylanus et al.20 (n=34) ACHA model NR Difference   
Mean sound field threshold, dB HL (SDb) 
 0.25 kHz 
 0.50 kHz 
 1 kHz 
 2 kHz 
 4 kHz 
 8 kHz 
 
40 
36 
28 
22 (SD 11.9) 
37 
55 (SD 21.3) 
 
39 
36 
22 (SD 8.3) 
25 
33 
43 (SD 22.3) 
 
p=ns 
p=ns 
p<0.01 
p=ns 
p=ns 
p<0.001 
Two tailed student t-test 
Maximum phoneme score (mean ± SD) Data NR Data NR 1.0% ± 5.4%, 
p=ns 
Two tailed student t-test 
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Speech in noise ratio improvement Data NR Data NR 1.1 ± 2.1 dB 
p<0.01 
Two tailed student t-test 
Snik et al.16-18 ACHA HC 200, 220   
Snik et al. 1992 16 (n=5) ACHA HC 220  “Standard Dutch phonetically balanced word 
lists consisting of 10 monosyllables” 
Maximum phoneme score, %, mean (SD) range 81.6 (8.7), 70 to 
90 
67.6 (22.2), 43 to 
90 
  
Speech recognition threshold, dB(A), mean (SD) range 39 (10.8), 20 to 
45 
(n=3) 
45 (5), 40 to 50 
  
Average difference between the sound field warble 
thresholds, dB  (ACHA minus BAHA) 
 0.25 kHz 
 0.5 kHz 
 1 kHz 
 2 kHz 
 4 kHz 
 8 kHz 
 
 
-6 
-5 
3 
4 
15 
0 
 
Snik et al. 1994 17 (n=14) HC 220, HC 200 “Phonetically balanced monosyllable” material 
used 
Patients with a statistically significant change in:  
HC 220 (n=5)  
- speech recognition in quiet score with BAHA Improved: 3 of 5 (40%); Deteriorated: 1 of 5 (20%)  
- speech to noise ratio score with BAHA No results for HC 220   
 
HC 200 (n=9)  
- speech recognition in quiet score with BAHA Improved: 0 of 9; Deteriorated: 1 of 9 (11%)   
- speech to noise ratio score with BAHA Improved: 5 of 9 (55%); Deteriorated: 1 of 9 (11%)   
Snik et al. 1998 18 (n=8) HC 200 “Sentence Recognition in Noise” test used 
Change in speech reception threshold in quiet (ACHA 
minus BAHA), mean dB (SD) 
-6.4 (3.7), p<0.05 significant deterioration  
Change in speech to noise ratio, mean dB (SD) 1.6 (1.0), p<0.05 significant improvement  
Note: study authors’ original terminology retained. ACHA = air-conduction hearing aid; CON = aetiology congenital; CSOM = aetiology chronic suppurative otitis media; NR = not 
reported; SD = standard deviation; dB SPL (sound pressure level) 
a  States that clinically, audibility improved by 5-15 dB at these frequencies (although figure does not seem to show that for 0.5 kHz) 
b SDs for each frequency not reported. States that the SD varied between 11.9 dB at 2 kHz and 21.3 dB at 8 kHz for ACHA, and between 8.3 dB at 1 kHz and 22.3 dB at 8 kHz for BAHA. 
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Table 4 Audiologic measures: BAHA versus unaided hearing 
Study and outcomes Unaided BAHA model Comparison Comment 
Béjar-Solar et al. 13 (n=11) Unaided BAHA Classic 300   
Sound field pure tone average threshold (1.25 to 3 kHz), 
dB HL  
64 19   
a Burrell et al. 19 (n=9) Unaided model NR   
Average sound field warble tone thresholds (0.5 to 4 
kHz), mean (SD), range, dBA 
49.4 (11.9), 40 
to 78  
30.6 (8.1), 22 to 43   
Sound field speech discrimination at 63 dBA, % correct, 
mean (SD), range 
74 (19.5), 50 to 
98b 
84 (22.3), 30 to 100    
a Cooper et al. 14  
Previous aid BC; CSOM (n=19), CON (n=16) 
Previous aid AC; CSOM (n=24), CON (n=9) 
Unaided HC200, 300, 220 P value  
Mean sound field warble tone thresholds, dB (dBA, 0.5-
4 kHz) 
Previous aid BC 
CSOM 63 
CON 62 
Previous aid AC 
CSOM 60 
CON 68 
Previous aid BC 
CSOM 35 
CON 26 
Previous aid AC 
CSOM 33 
CON 28 
 
p<0.01 
p<0.01 
 
p<0.01 
p<0.01 
Student’s t-test 
Mean sound field speech discrimination score (at 63 
dB), % correct  
Previous aid BC 
CSOM 17 
CON 3 
Previous aid AC 
CSOM 19 
CON 17 
Previous aid BC 
CSOM 72 
CON 85 
Previous aid AC 
CSOM 72 
CON 82 
 
p=NR 
p=NR 
 
p=NR 
p=NR 
Boothroyd word list material used  
Student’s t-test 
 
Kompis et al.12 (n=7) Unaided Divino P value  
Average improvement in sound-field thresholds over all 
frequencies compared with unaided, dB 
 28.0 p<0.0001 Wilcoxon matched pairs signed rank test 
Speech recognition thresholds in quiet using two-digit 
numbers, dB (assume value is mean) 
54 23 p=NR Freiburger numbers material 
Speech recognition scores for monosyllabic words in 
quiet, % correct (assume mean) 
 50 dB SPL 
 65 dB SPL  
 80 dB SPL 
 
 
5 
15 
50 
 
 
45 
90 
95 
 
 
p=NR 
Freiburger monosyllabic words material 
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Speech recognition threshold in noise (noise presented 
from front or back), dB 
Front 
Back 
 
 
12 
9 
omnidirectional / 
directional mode  
3 / 4 
3 / 1 
 Basler sentence test material 
Note: study authors’ original terminology retained. AC = air-conduction; BC = bone-conduction; CON = aetiology congenital; CSOM = aetiology chronic suppurative otitis media; 
NR = not reported; SD = standard deviation. 
a Burrell 1996 and Cooper 1996: BAHA data are also presented in Table 2 and Table 3 for the comparisons with bone-conduction hearing aids and air-conduction hearing aids, respectively. 
b Data missing for two participants 
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Table 5 Audiologic measures: unilateral BAHA versus bilateral BAHAs 
Study and outcomes Unilateral Bilateral Comparison Comment 
Bosman et al. 5,21 (n=25) Unilateral Bilateral P value “Standardised sentence material” used.  
Repeated measures ANOVA applied. 
Speech reception threshold in quiet (dBA) 41.5 37.5 p<0.001  
SNR (dBA), noise from the baffle side -0.7 -3.2 p<0.001  
SNR (dBA), noise from shadow side -3.4 -4.0 p>0.05  
Directional hearing at 0.5 kHz, %   
 - Correct localisation  
 - Localisation within 30°  
 - Lateralisation  
 
23 
56 
54 
 
42 a  
90 a 
85 a 
 
 
 
p<0.001 across 
all 
observations 
 
 
 
Directional hearing at 2 kHz, %  
 - Correct localisation  
 - Localisation within 30°  
 - Lateralisation 
 
24 
58 
64 
 
45 a 
89 a 
87 a 
Proportion of responses corresponding to the fitted 
BAHA side at:  0.5 kHz 
   2 kHz 
 
75.3% 
70.3% 
 
45.7% 
48.8% 
  
Binaural masking level difference signal to noise ratio Bilateral BAHAs (n=9) 
S0N0  SπN0  S0Nπ 
  
  0.125 kHz 
  0.25 kHz 
  0.5 kHz 
  1 kHz 
2.2  3.8  -3.7 
0.1  -6.0  -5.1 
0.4  -5.9  -3.9 
0.4 -  -3.3  -4.9 
p<0.001  
p<0.001 
p<0.001 
p>0.05 (ns) 
 
Dutt et al. 22 (n=11) Unilateral  Bilateral   
Speech in quiet (Boothroyd word list cumulative 
scores, 30 words) at: 
 30 dB intensity levels 
 40 dB intensity levels 
 50 dB intensity levels 
 60 dB intensity levels 
 70 dB intensity levels 
 80 dB intensity levels 
Best response 
 
1 
13 
20 
25 
27 
30 
 
 
5 
19 
24 
28 
29 
30 
  
Speech in quiet (Bamford-Kowal-Bench sentences) All 11 patients scored 100% with right, left and bilateral 
BAHAs. 
 
Speech in noise (Bamford-Kowal-Bench cumulative Best response    
 28 
sentence scores) at: 
 plus 10 SNR 
 zero SNR 
 minus 10 SNR 
 
99 
80 
0 
 
100 
81 
1 
Plomp test, % correct score (mean (SD), range) - 
sound front, noise front   
 
Left side: 76 
(11.7), 56-93 
Right side: 77.3 
(11.7), 58-90 
 
82.4 (13.3), 60-97 
  
 - sound front, noise left Left side: 40.1 
(25.3), 2-71 
Right side: 84.1 
(11.2), 55-97 
71.1 (14.9), 44-95   
 - sound front, noise right Left side: 88.2 
(9.0), 72-100 
Right side: 45.8 
(22.1), 13-88 
79.5 (11.6), 58-93   
Priwin et al.23 (n=12) Unilateral Bilateral P Value  
Average difference in sound field tone thresholds (at 
0.25 to 8 kHz), dB 
- sound presented in front, at best side and from 
behind patients 
- sound presented at shadow side 
 
 
2 to 7 dB improvement with bilateral 
 
5 to 15 dB improvement with bilateral 
 
Speech recognition in quiet, average threshold, dB HL Best side 
38.7 
 
33.3 
 
p=0.001 
“Phonetically balanced three-word sentences, 
extracted from five-word sentence tests”. 
Student’s paired t-test. 
Speech in noise (change in SNR with bilateral BAHA), 
masking noise presented: 
- at best side 
- at shadow side 
- as surrounding noise  
 
 
3.1 dB improvement 
1.0 dB deterioration 
2.8 dB improvement 
 
Directional hearing Best/Shadow 
side 
   
% of correct answersb 
 0.5 kHz 
 2.0 kHz 
 
12 / 11 
8 / 10 
 
25 
23 
  
% of answers within 30° of correct responseb     
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 0.5 kHz 
 2.0 kHz 
23 / 30 
28 / 27 
53 
51 
Binaural masking level differencec: Bilateral BAHAs (n=12)  
 0.25 kHz: 
  - SπN0 
  - S0Nπ 
 
- threshold changes within 3 dB except for 2 patients. 
- threshold changes between -18 to 3 dB, mean -5 dB. 
 
 0.5 kHz: 
  - SπN0 
  - S0Nπ 
 
- average threshold change  2 dB 
- average threshold change -4 dB 
 
 1 kHz: 
  - SπN0 
  - S0Nπ 
 
- average threshold change  3 dB 
- average threshold change -3 dB 
 
Priwin et al.3  
(Unilateral BAHA users n=6, Bilateral BAHA users 
n=3) 
One BAHA 
(Unilateral n=6 
/ Bilateral n=3) 
Two BAHAs 
(Bilateral n=3) 
  
Sound field  average  tone thresholds, dB HL  
Mean (SD, range) 
24 (5, 20 to 32) /  
30 (5, 25 to 35) 
 
25 (5, 20 to 30) 
  
Speech recognition in noise, median score (%) 
 SNR 0 dB  
 SNR 4 dB 
 SNR 6 dB  
 
87 / 69 
92 / 79 
98 / 97 
 
88 
93 
90 
 “Phonetically balanced three-word sentences, 
extracted from five-word sentence tests” 
Localisation of sound at 0.5 kHz, mean % 
Correct score d    - 50 dB 
    - 60 dB 
Lateralisations score d  - 50 dB 
    - 60 dB 
 
20 / 20 
28 / 20 
68 / 60 
70 / 68 
 
50 
50 
86 
94 
  
Localisation of sound at 3 kHz, mean % 
Correct scored   - 50 dB 
    - 60 dB 
Lateralisations scored  - 50 dB 
    - 60 dB  
 
28 / 16 
37 / 18 
60 / 68 
72 / 56 
 
50 
57 
80 
96 
  
Note: study authors’ original terminology retained. SNR = signal-to-noise ratio; S0N0  = in-phase tone stimuli and in-phase noise bands;  SπN0 =  180˚ out-of-phase tone stimuli and in-phase 
noise bands; S0Nπ = in-phase tone stimuli and 180˚ out-of-phase noise bands. 
a  p<0.05 versus the chance level for that outcome.  For correct localisation the chance level is 14.3%, (95% CI 32), for localisation within 30° the chance level is 42.9% (95% CI 64 ) and 
for lateralisation the chance level is 50% (95% CI 32). 
b For correct score, the chance level is 8.3%, for answers within 30° the chance level is 25%. 
c  Relative threshold change in dB from the condition ‘signal and noise in phase at both sides’. 
d For correct localisation score, the chance level is 20%, for lateralization score, the chance level is 68%. 
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Table 6 Adverse effects reported in included studies 
Béjar-Solar et al.13 (n=11)  
Major complications 0/11 
Unable to obtain osseointegration (following impact to 
mastoid area 24 hrs after discharge from first stage) 
1/11 
Types of skin reactions, n of observations (%) Total observations: 82 
 - no irritation 71/82 (87) 
 - slight erythema 7/82 (8) 
 - erythema and moisture 3/82 (4) 
 - red and moist with granulation tissue 1/82 (1) 
 - infection leading to loss of implant 0 
Mylanus et al.20 (n=34)  
Surgery uneventful in all patients.  
2 stopped using their BAHA (after 3 months and 2.5 years) due to pain, no explanation found. 
Snik et al.18  (n=39)  
Total re-operations: 6/39 (15.4%) [loss due to inflammation (1) or trauma (2), removal due to pain (1), 
reduction of subcutaneous layer (2)] 
 
 
 
 
 
 
 
